Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma
Condition(s):Colorectal AdenocarcinomaLast Updated:March 25, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Colorectal AdenocarcinomaLast Updated:March 25, 2021Terminated
Condition(s):Colorectal AdenocarcinomaLast Updated:August 4, 2022Recruiting
Condition(s):Colorectal AdenocarcinomaLast Updated:March 8, 2021Withdrawn
Condition(s):Colorectal AdenocarcinomaLast Updated:March 28, 2012Unknown status
Condition(s):Colorectal AdenocarcinomaLast Updated:December 8, 2023Recruiting
Condition(s):MSS; pMMR; Metastatic Colorectal AdenocarcinomaLast Updated:October 5, 2021Unknown status
Condition(s):Colorectal AdenocarcinomaLast Updated:June 4, 2009Completed
Condition(s):Metastatic Colorectal AdenocarcinomaLast Updated:August 10, 2022Terminated
Condition(s):Colorectal AdenocarcinomaLast Updated:February 23, 2024Completed
Condition(s):Metastatic Colorectal AdenocarcinomaLast Updated:January 22, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.